Glucagon: A Checklist Guide to Its Meaning and Application Scope
Abstract: Glucagon, a 29-amino-acid peptide hormone, is critical in glucose homeostasis and emergency hypoglycemia treatment. This checklist guide explores its meaning and application scope within the peptide industry. Current market trends show a CAGR of 8.5% (2023-2030), driven by diabetes and obesity therapeutics. Leading brands (e.g., Novo Nordisk, Eli Lilly) dominate via stable synthetic analogs, while emerging manufacturers offer cost-competitive generic peptides. Technical advantages include rapid onset and specificity; drawbacks involve short half-life and stability issues. Product parameters (purity >98%, endotoxin <0.5 EU/mg) and certifications (GMP, ISO 9001) are vital for quality. Logistics require cold-chain (-20°C) to maintain bioactivity. Selection tips prioritize supplier audits, batch consistency, and regulatory compliance. Industry outlook remains robust, with R&D focusing on long-acting formulations.